Suárez-Cabrera, A.; Fiallo-Suárez, D.V.; Stuckey, R.; Uroz-de la Iglesia, M.L.; Florido, Y.; Lemes-Castellano, A.; Perera-Álvarez, M.Á.; Luzardo-Henríquez, H.; de la Nuez, H.; Fernández-Caldas, P.;
et al. Genetic Testing at Diagnosis Has Prognostic Value in Patients with Chronic Lymphocytic Leukemia including at Early Stages. Diagnostics 2022, 12, 1802.
https://doi.org/10.3390/diagnostics12081802
AMA Style
Suárez-Cabrera A, Fiallo-Suárez DV, Stuckey R, Uroz-de la Iglesia ML, Florido Y, Lemes-Castellano A, Perera-Álvarez MÁ, Luzardo-Henríquez H, de la Nuez H, Fernández-Caldas P,
et al. Genetic Testing at Diagnosis Has Prognostic Value in Patients with Chronic Lymphocytic Leukemia including at Early Stages. Diagnostics. 2022; 12(8):1802.
https://doi.org/10.3390/diagnostics12081802
Chicago/Turabian Style
Suárez-Cabrera, Alexia, Dolly Viviana Fiallo-Suárez, Ruth Stuckey, Marta Luna Uroz-de la Iglesia, Yanira Florido, Angelina Lemes-Castellano, Miguel Ángel Perera-Álvarez, Hugo Luzardo-Henríquez, Haridian de la Nuez, Paula Fernández-Caldas,
and et al. 2022. "Genetic Testing at Diagnosis Has Prognostic Value in Patients with Chronic Lymphocytic Leukemia including at Early Stages" Diagnostics 12, no. 8: 1802.
https://doi.org/10.3390/diagnostics12081802
APA Style
Suárez-Cabrera, A., Fiallo-Suárez, D. V., Stuckey, R., Uroz-de la Iglesia, M. L., Florido, Y., Lemes-Castellano, A., Perera-Álvarez, M. Á., Luzardo-Henríquez, H., de la Nuez, H., Fernández-Caldas, P., de la Iglesia, S., Gómez-Casares, M. T., & Bilbao-Sieyro, C.
(2022). Genetic Testing at Diagnosis Has Prognostic Value in Patients with Chronic Lymphocytic Leukemia including at Early Stages. Diagnostics, 12(8), 1802.
https://doi.org/10.3390/diagnostics12081802
